Vicplas International Ltd
SGX:569

Watchlist Manager
Vicplas International Ltd Logo
Vicplas International Ltd
SGX:569
Watchlist
Price: 0.091 SGD -1.09% Market Closed
Market Cap: S$46.6m

Net Margin

-2%
Current
Declining
by 2.9%
vs 3-y average of 0.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2%
=
Net Income
S$-2.4m
/
Revenue
S$115.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2%
=
Net Income
S$-2.4m
/
Revenue
S$115.8m

Peer Comparison

Country Company Market Cap Net
Margin
SG
Vicplas International Ltd
SGX:569
46.5m SGD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.9B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.1B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.7B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.5B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Lower than 71% of companies in Singapore
Percentile
29th
Based on 1 060 companies
29th percentile
-2%
Low
-230 800 561.6% — -1.2%
Typical Range
-1.2% — 9%
High
9% — 5 696 822.3%
Distribution Statistics
Singapore
Min -230 800 561.6%
30th Percentile -1.2%
Median 2.9%
70th Percentile 9%
Max 5 696 822.3%

Vicplas International Ltd
Glance View

Market Cap
46.6m SGD
Industry
Health Care

VicPlas International Ltd. operates as an investment holding company, which engages in the research, design, development, and manufacture of medical devices and plastic building products. The firm designs, develops and manufactures sterile and non-sterile medical devices through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. The firm manufactures and distributes piping systems for diverse industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies, through its subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.

Intrinsic Value
0.159 SGD
Undervaluation 43%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2%
=
Net Income
S$-2.4m
/
Revenue
S$115.8m
What is Vicplas International Ltd's current Net Margin?

The current Net Margin for Vicplas International Ltd is -2%, which is below its 3-year median of 0.8%.

How has Net Margin changed over time?

Over the last 3 years, Vicplas International Ltd’s Net Margin has decreased from 6.8% to -2%. During this period, it reached a low of -2% on Aug 31, 2025 and a high of 6.8% on Jul 1, 2022.

Back to Top